Paper Review Records
All Paper Review Records
15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
144
days
Bioactivation and reactivity research advances – 2025 year in review
Authors
Joyce Liu; Upendra A. Argikar; Pietro Brunetti; Maria Chatzopoulou; Sungjoon Cho; Alf Claesson; Deepika Dhaware; Jakob Lang; Bin Ma; Shuguang Ma; Hlaing Maw; Grover P. Miller; Simone Schadt; Herana Kamal Seneviratne; Lloyd Wei Tat Tang; Caroline Wei; S. Cyrus KhojastehShow moreShow less
Affiliations
1. Department of Drug Metabolism and Pharmacokinetics, Genentech, Inc; 2. Non-clinical Development, Gates Medical Research Institute; 3. Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd; 4. UCB; 5. Awametox AB; 6. DMPK and Safety Sciences, Orion Pharma; 7. Department of Drug Metabolism and Pharmacokinetics, Gilead Sciences, Inc; 8. Drug Metabolism and Pharmacokinetics, Boehringer Ingelheim Pharmaceuticals, Inc; 9. Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences; 10. Department of Chemistry and Biochemistry, University of Maryland, Baltimore County; 11. Pharmacokinetics, Dynamics, and Metabolism, Pfizer Inc; 12. Quantitative Clinical Pharmacology, Daiichi Sankyo IncShow moreShow less
43
days
Drug transporters in drug disposition – highlights from the year 2025
Authors
Philip Sandoval; Pallabi Mitra; Masanori Nakakariya; Diane Ramsden; Charles J. Rotter; Ning Ding; Paresh P. ChotheShow moreShow less
Affiliations
1. Takeda Development Center Americas, Inc. (TDCA); 2. Department of Drug Metabolism and Pharmacokinetics, Boehringer Ingelheim Pharmaceuticals Inc.; 3. Takeda Pharmaceutical Company Limited; 4. Preclinical Development, Korro Bio, Inc.; 5. Rapport Therapeutics; 6. Drug Metabolism and Pharmacokinetics, Oncology Research and Development, AstraZenecaShow moreShow less
178
days
Herbal supplements and anti-tuberculosis therapy: unlocking hidden interactions for better multidrug-resistant tuberculosis management
Authors
Siva Bhukya; Ravi Adinarayan Somabattini; Neelanjan Chowdhury; Sathi Sarkar; Anish Kumar Das; Kabita Mahato; Hanumu Korra; Satheesh Kumar NanjappanShow moreShow less
Affiliations
1. Department of Natural Products, National Institute of Pharmaceutical Education and Research (NIPER) KolkataShow moreShow less
57
days
Biotransformation research advances—2025 year in review
Authors
Lionel Cheruzel; Upendra A. Argikar; Pietro Brunetti; Maria Chatzopoulou; Luying Chen; Sungjoon Cho; Deepika Dhaware; Carley J. S. Heck; Chandrashekhar Honrao; S. Cyrus Khojasteh; Jed N. Lampe; Jakob Lang; Bin Ma; Shuguang Ma; Karoline Rehm; Jessica A. Rowley; Herana Kamal Seneviratne; Hyeonglim Seo; Lloyd Wei Tat Tang; Yue-Ting Wang; Caroline WeiShow moreShow less
Affiliations
1. Department of Drug Metabolism and Pharmacokinetics, Genentech, Inc.; 2. Non-clinical Development, Gates Medical Research Institute; 3. Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd; 4. UCB; 5. Department of Pharmaceutical Sciences, China Innovation Center of Roche; 6. DMPK and Safety Sciences, Orion Pharma; 7. Pharmacokinetics, Dynamics, and Metabolism, Pfizer Inc.; 8. Pharmacokinetics, Dynamics, Metabolism, and Bioanalytics, Merck & Co., Inc.; 9. Department of Pharmaceutical Sciences, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; 10. Department of Drug Metabolism and Pharmacokinetics, Gilead Sciences, Inc.; 11. Department of Chemistry and Biochemistry, University of Maryland; 12. Quantitative, Translational & ADME Sciences (QTAS), AbbVie; 13. Quantitative Clinical Pharmacology, Daiichi Sankyo Inc.Show moreShow less
87
days
Pharmacomicrobiomics in precision pharmacotherapy: bidirectional microbial-drug interactions as a key determinant of therapeutic response
Authors
Serap Yalçın Azarkan; Habibe Sema Arslan Ünal; Sevinç AkçayShow moreShow less
Affiliations
1. Department of Medical Pharmacology, Faculty of Medicine, Kırşehir Ahi Evran University; 2. Department of Medical Genetics, Faculty of Medicine, Kırşehir Ahi Evran University; 3. Department of Molecular Biology and Genetics, Faculty of Science and Art, Kırşehir Ahi Evran UniversityShow moreShow less
140
days
Population pharmacokinetics of levofloxacin: a systematic review
Authors
Yifan Ding; Xianghai Zeng; Jing Zou; Yuxue Zhou; Jiali Zhang; Zhao Chang; Shengnan Zhang; Meng LvShow moreShow less
Affiliations
1. Department of Pharmacy, Children’s Hospital Affiliated to Zhengzhou UniversityShow moreShow less
FAQ
How long does DRUG METABOLISM REVIEWS take to review a manuscript?
As of 2026-11-19, CrushSCI has 15 complete review records for DRUG METABOLISM REVIEWS. The fastest paper went from submission to acceptance in 26 days (Cytochrome P450-derived arachidonic acid metabolites as emerging therapeutic targets in menopause-associated cardiac hypertrophy, received 2026-04-01, accepted 2026-04-27); the slowest took 178 days. The average is 90.4 days and the median is 83 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
